Kevin Chen, MD, PhD Candidate
MD/PhD Student
Boston University Chobanian & Avedisian School of Medicine
Molecular and Translational Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Wada M, Zhang H, Fang L, Feng J, Tse CO, Zhang W, Chen Q, Sha S, Cao Y, Chen KH, Pinz KG, Chen X, Fan XX, Jiang X, Ma Y. Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies. Stem Cell Rev Rep. 2020 Apr; 16(2):369-384. PMID: 32008159; DOI: 10.1007/s12015-019-09937-9;
     
  2. Yan LE, Zhang H, Wada M, Fang L, Feng J, Zhang W, Chen Q, Cao Y, Pinz KG, Chen KH, Petrov JC, Chen X, Leung LH, Fan XX, Senzel L, Jiang X, Ma Y, Tse W. Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy. Stem Cell Rev Rep. 2020 Apr; 16(2):385-396. PMID: 31970687; DOI: 10.1007/s12015-019-09948-6;
     
  3. Bell K, Skier K, Chen KH, Gergen JP. Two pair-rule responsive enhancers regulate wingless transcription in the Drosophila blastoderm embryo. Dev Dyn. 2020 Apr; 249(4):556-572. PMID: 31837063; DOI: 10.1002/dvdy.142;
     
  4. Petrov JC, Wada M, Pinz KG, Yan LE, Chen KH, Shuai X, Liu H, Chen X, Leung LH, Salman H, Hagag N, Liu F, Jiang X, Ma Y. Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia. Leukemia. 2018 Jun; 32(6):1317-1326. PMID: 29515236; PMCID: PMC5990523; DOI: 10.1038/s41375-018-0075-3;
     
  5. Pinz KG, Yakaboski E, Jares A, Liu H, Firor AE, Chen KH, Wada M, Salman H, Tse W, Hagag N, Lan F, Leung EL, Jiang X, Ma Y. Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells. Oncotarget. 2017 Dec 22; 8(68):112783-112796. PMID: 29348865; PMCID: PMC5762550; DOI: 10.18632/oncotarget.22626;
     
  6. Chen KH, Wada M, Pinz KG, Liu H, Shuai X, Chen X, Yan LE, Petrov JC, Salman H, Senzel L, Leung ELH, Jiang X, Ma Y. A compound chimeric antigen receptor strategy for targeting multiple myeloma. Leukemia. 2018 Feb; 32(2):402-412. PMID: 28951562; PMCID: PMC5808076; DOI: 10.1038/leu.2017.302;
     
  7. Chen KH, Wada M, Pinz KG, Liu H, Lin KW, Jares A, Firor AE, Shuai X, Salman H, Golightly M, Lan F, Senzel L, Leung EL, Jiang X, Ma Y. Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor. Leukemia. 2017 Oct; 31(10):2151-2160. PMID: 28074066; PMCID: PMC5629371; DOI: 10.1038/leu.2017.8;
     
  8. Chen KH, Wada M, Firor AE, Pinz KG, Jares A, Liu H, Salman H, Golightly M, Lan F, Jiang X, Ma Y. Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies. Oncotarget. 2016 Aug 30; 7(35):56219-56232. PMID: 27494836; PMCID: PMC5302909; DOI: 10.18632/oncotarget.11019;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 5 distinct years, with a maximum of 3 publications in 2017

YearPublications
20161
20173
20181
20191
20202

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Cell Therapy
Regenerative Medicines
Stem Cell Transplantation
Immunotherapy, Adoptive Cellular
Developmental Biology
Contact for Mentoring:

Chen's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (49) concept(s)
_
Similar People
See all (60) people
_